Lung injury during CPB: Pathomechanisms and clinical relevance

Interactive Cardiovascular and Thoracic Surgery

Volumn 4, Issue 5, 2005, Pages 381-382

  Schlensak, Christian ^a   Beyersdorf, Friedhelm ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN;

BLOOD CELL; CARDIOPULMONARY BYPASS; DISEASE SEVERITY; EDITORIAL; GAS EXCHANGE; HEART SURGERY; HUMAN; INFLAMMATION; LUNG FUNCTION; LUNG INJURY; LUNG LAVAGE; LUNG PERFUSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SYMPTOM;

EID: 30744449975     PISSN: 15699293     EISSN: 15699293     Source Type: Journal    
DOI: 10.1510/icvts.2005.117853     Document Type: Editorial

References (23)

1. Vedin J, Jensen U, Ericsson A, Samuelsson S, Vaage J. Pulmonary hemodynamics and gas exchange in off pump coronary artery bypass grafting. Interact CardioVasc Thorac Surg 2005;4:493-497.
2. Abel RM, Buckley MJ, Austen WG, Barnett GO, Beck CHJ, Fischer JE. Etiology, incidence, and prognosis of renal failure following cardiac operations. Results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg 1976;71:323-333.
3. Andersson LG, Ekroth R, Bratteby LE, Hallhagen S, Wesslen O. Acute renal failure after coronary surgery - a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg 1993;41:237-241.
4. Fischer UM, Weissenberger WK, Warters RD, Geissler HJ, Allen SJ, Mehlhorn U. Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 2002;17:401-406.
5. Treacher DF, Sabbato M, Brown KA, Gant V. The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass. Perfusion 2001;16:67-73.
6. Bund M, Seitz W, Uthoff K, Krieg P, Struber M, Piepenbrock S. Monitoring of respiratory function before and after cardiopulmonary bypass using side-stream spirometry. Eur J Anaesthesiol 1998;15:44-49.
7. Chai PJ, Williamson JA, Lodge AJ, Daggett CW, Scarborough JE, Meliones JN, Cheifetz IM, Jaggers JJ, Ungerleider RM. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1999;67:731-735.
8. Friedman M, Sellke FW, Wang SY, Weintraub RM, Johnson RG. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation 1994;90:II262-II268.
9. Serraf A, Sellak H, Herve P, Bonnet N, Robotin M, Detruit H, Baudet B, Mazmanian MG, Planche C. Vascular endothelium viability and function after total cardiopulmonary bypass in neonatal piglets. Am J Respir Crit Care Med 1999;159:544-551.
10. Weiss YG, Merin G, Koganov E, Ribo A, Oppenheim-Eden A, Medalion B, Peruanski M, Reider E, Bar-Ziv J, Hanson WC, Pizov R. Postcardiopulmonary bypass hypoxemia: a prospective study on incidence, risk factors, and clinical significance. J Cardiothorac Vasc Anesth 2000;14:506-513.
11. Sinclair DG, Haslam PL, Quinlan GJ, Pepper JR, Evans TW. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest 1995;108:718-724.
12. Stiller B, Sonntag J, Dahnert I, Alexi-Meskishvili V, Hetzer R, Fischer T, Lange PE. Capillary leak syndrome in children who undergo cardiopulmonary bypass: clinical outcome in comparison with complement activation and C1 inhibitor. Intensive Care Med 2001;27:193-200.
13. Hammermeister KE, Burchfiel C, Johnson R, Grover FL. Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation 1990;82:IV380-IV389.
14. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, Petty TL, Hyers TM. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 1983;98:593-597.
15. Milot J, Perron J, Lacasse Y, Letourneau L, Cartier PC, Maltais F. Incidence and predictors of ARDS after cardiac surgery. Chest 2001;119:884-888.
16. Fitch JC, Rollins S, Matis L, Alford B, Aranki S, Collard CD, Dewar M, Elefteriades J, Hines R, Kopf G, Kraker P, Li L, O'Hara R, Rinder C, Rinder H, Shaw R, Smith B, Stahl G, Shernan SK. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 1999;100:2499-2506.
17. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-857.
18. Mendler N, Heimisch W, Schad H. Pulmonary function after biventricular bypass for autologous lung oxygenation. Eur J Cardiothorac Surg 2000;17:325-330.
19. Richter JA, Meisner H, Tassani P, Barankay A, Dietrich W, Braun SL. Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting. Ann Thorac Surg 2000;69:77-83.
20. Sievers HH, Freund-Kaas C, Eleftheriadis S, Fischer T, Kuppe H, Kraatz EG, Bechtel JF. Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy. Ann Thorac Surg 2002;74:1167-1172.
21. Suzuki T, Fukuda T, Ito T, Inoue Y, Cho Y, Kashima I. Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann Thorac Surg 2000;69:602-606.
22. Schlensak C, Doenst T, Preusser S, Wunderlich M, Kleinschmidt M, Beyersdorf F. Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischemia of the lung in piglets: assessment of bronchial artery blood flow with fluorescent microspheres. Eur J Cardiothorac Surg 2001;19:326-331.
23. Schlensak C, Doenst T, Preusser S, Wunderlich M, Kleinschmidt M, Beyersdorf F. Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal pig model. J Thorac Cardiovasc Surg 2002;123:1199-1205.